{"height":"190","image_url":null,"blog_url":"https://ctd-gim.hatenablog.com/","provider_name":"Hatena Blog","title":"\u5de8\u7d30\u80de\u6027\u52d5\u8108\u708e\u306e80\u6b73\u4ee5\u4e0a\u306e\u60a3\u8005\u3078\u306eTocilizumab\u306e\u6709\u52b9\u6027\u30fb\u5b89\u5168\u6027","url":"https://ctd-gim.hatenablog.com/entry/2021/05/21/203152","blog_title":"\u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a","author_url":"https://blog.hatena.ne.jp/CTD_GIM/","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fctd-gim.hatenablog.com%2Fentry%2F2021%2F05%2F21%2F203152\" title=\"\u5de8\u7d30\u80de\u6027\u52d5\u8108\u708e\u306e80\u6b73\u4ee5\u4e0a\u306e\u60a3\u8005\u3078\u306eTocilizumab\u306e\u6709\u52b9\u6027\u30fb\u5b89\u5168\u6027 - \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","categories":["\u8840\u7ba1\u708e","\u6cbb\u7642\u85ac","\u5de8\u7d30\u80de\u6027\u52d5\u8108\u708e"],"description":"\u201cAssessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis\u201d Arthritis Res Ther. 2021;23(1):143. \u5de8\u7d30\u80de\u6027\u52d5\u8108\u708e\uff08Giant Cell Arteritis: GCA\uff09\u3078\u306eTocilizumab\uff08TCZ\uff09\u306e\u6709\u52b9\u6027\u306b\u3064\u3044\u3066\u306fGiACTA trial(N Engl J Med. 2017;377(4):317-328.)\u3067\u5b9f\u8a3c\u3055\u308c\u3066\u3044\u308b\u304c\u3001\u5e73\u5747\u5e74\u9f6260\u4ee3\u5f8c\u534a\uff0869.5\u00b18.5\u6b73\uff09\u304c\u5bfe\u8c61\u3068\u306a\u3063\u3066\u304a\u308a\u9ad8\u9f62\u8005\u3078\u306e\u2026","version":"1.0","type":"rich","width":"100%","published":"2021-05-21 20:31:52","provider_url":"https://hatena.blog","author_name":"CTD_GIM"}